Thorsten Wirkes
Co-Founder and Managing Director @ Bertelsmann Healthcare Investments
New York, United States
Thorsten Wirkes is a Series B investor at Bertelsmann Healthcare Investments in New York focused on Health Care and Medical. Thorsten Wirkes is based out of New York and is the Co-Founder and Managing Director of Bertelsmann Healthcare Investments. Thorsten previously worked at Phare Health as an Investor. Thorsten Wirkes attended the WHU – Otto Beisheim School of Management.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Thorsten Wirkes invests in
Stages Thorsten Wirkes invests in
Countries Thorsten Wirkes invests in
Investment Focus
Industry
- Health Care 5 (83%)
- Medical 2 (33%)
- Pharmaceutical 2 (33%)
- FinTech 1 (17%)
- Hospital 1 (17%)
Stage
- Series B 3 (50%)
- Seed 2 (33%)
- Series A 1 (17%)
Country
- United States 3 (50%)
- Israel 1 (17%)
- United Kingdom 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
QuantHealth
|
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $45M / Series B / Aug 04, 2026 | |
Andel
|
Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications. | $4.5M / Seed / Oct 20, 2025 | |
Phare Health
|
Phare Health transforms the back office of healthcare, making it more efficient, accurate, and resillient. | $3.1M / Seed / Nov 22, 2023 | |
|
QuantHealth
|
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $15M / Series A / Aug 30, 2023 | |
Paytient
|
Paytient helps people make better healthcare decisions by improving their ability to pay for care. We do this by bundling or embedding payment solutions like Paytient's Health Payment Account (HPA) or the Medicare Prescription Payment Plan alongside commercial, individual ACA, and Medicare plans. Armed with the power to decide how and whenthey pay for care, our users change their behavior in ways that improve their health and lower costs for everyone, which benefits the plan sponsor. By 2025, Paytient will serve 25M lives and 6,000 enterprise clients including leading employers and payers such as Anthem, Centene, Cigna, R.R. Donnelley, and Hyatt Hotels. The company has earned a 90 NPS and 4.9 stars on Trustpilot. | $33M / Series B / Jan 10, 2023 | |
SubjectWell
|
SubjectWell is the risk-free clinical trials marketplace for patient recruitment | $35M / Series B / Oct 18, 2022 |
Co-Investors
About Bertelsmann Healthcare Investments
Bertelsmann Healthcare Investments (BHI) is a recently launched, independent transatlantic investment firm focused on healthcare, backed by Bertelsmann Investments. It targets high-growth, technology-driven healthcare companies, providing capital from early stages through expansion, along with sector expertise and networks.
Bertelsmann Healthcare Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Thorsten Wirkes
Co-Founder and Managing Director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Thorsten Wirkes invest in?
Thorsten Wirkes invests primarily in Health Care, Medical and Pharmaceutical startups, most often at Series B and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Thorsten Wirkes last invest?
The most recent investment recorded for Thorsten Wirkes closed in Aug 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
